Reports for MINT PHARMACEUTICALS INC

Company Name

MINT PHARMACEUTICALS INC

Totals

Shortage reports

143

Actual shortage: 17 (12%)
Anticipated shortage: 0 (0%)
Avoided shortage: 1 (1%)
Resolved: 125 (87%)

Discontinuation Reports

29

To be discontinued: 0 (0%)
Discontinued: 29 (100%)
Reversed: 0 (0%)

Late reports

34 (20%)

Overdue reports

4 (24%)

Shortage reports
Brand name Strength Dosage Status Date Created Date Updated Reports
MINT-TRAMADOL/ACET 37.5MG 325MG TABLET Resolved 2019-10-09 2019-12-10 95944
MINT-ZOLMITRIPTAN 2.5MG TABLET Resolved 2020-04-25 2024-12-05 113199
MINT-ZOPICLONE 5MG TABLET Resolved 2020-07-13 2020-11-03 120139

Showing 141 to 143 of 143

Discontinuation reports
Brand name Strength Dosage Status Date Created Date Updated Reports
MINT-RIZATRIPTAN ODT 5MG TABLET (ORALLY DISINTEGRATING) Discontinued 2017-06-21 2017-07-01 13544
MINT-RIZATRIPTAN ODT 10MG TABLET (ORALLY DISINTEGRATING) Discontinued 2017-06-21 2017-07-01 13553
MINT-ROSUVASTATIN 5MG TABLET Discontinued 2019-10-09 2019-10-10 95897
MINT-ROSUVASTATIN 10MG TABLET Discontinued 2019-10-09 2019-10-10 95900
MINT-ROSUVASTATIN 20MG TABLET Discontinued 2019-10-09 2019-10-10 95903
MINT-ROSUVASTATIN 40MG TABLET Discontinued 2019-10-09 2019-10-10 95907
MINT-SOLIFENACIN 5MG TABLET Discontinued 2019-10-09 2019-10-10 95913
MINT-SOLIFENACIN 10MG TABLET Discontinued 2019-10-09 2019-10-10 95916
MINT-ZOLMITRIPTAN ODT 2.5MG TABLET (ORALLY DISINTEGRATING) Discontinued 2017-06-21 2017-07-01 13540

Showing 21 to 29 of 29